Atlas Trials

Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease

Clinical trial NCT05531266 · UNKNOWN

Trial details

NCT number
NCT05531266
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
aGVHD
Start date
2022-09-01
Primary completion
2024-03-01
Enrollment
182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.